- University of Chicago, Pritzker School of Medicine
Internship / Residency
- General Surgery & Urology - University of Chicago
- Diplomate, American Board of Urology
Urologist Dr. Nejd Alsikafi serves patients who have prostate, bladder, kidney or testicle cancer. He consults with medical oncologists and patients on available treatment options, performs surgery and monitors patients who may need surgical intervention in the future.
Procedures Dr. Alsikafi performs include robotic-assisted laparoscopic prostatectomies and genitourinary reconstructive surgery. He also treats kidney stones, kidney and bladder infections, incontinence, erectile dysfunction, male infertility and prostate disorders.
Dr. Alsikafi earned a medical degree from the Pritzker School of Medicine at the University of Chicago. Following medical school, he completed both a general surgery and urology residency at the University of Chicago. Additionally, he completed a fellowship in urologic trauma and reconstruction at the University of California, San Francisco.
Dr. Alsikafi served as clinical associate professor at Loyola University Medical Center in Maywood, Illinois, where he served as co-director of the urologic reconstruction fellowship.
Dr. Alsikafi is a Diplomate of the American Board of Urology. He has been published in the Journal of Urology, a publication for which he also serves as a reviewer. He is a member of several professional organizations including, the American Urological Association, Society of Genitourinary Reconstructive Surgeons and the Chicago Urologic Society.
Dr. Alsikafi was inspired to become a doctor because of his desire to help people. He says, “My father was a physician who was an excellent role model. I chose urology specifically because it was a beautiful blend of surgery and medical management. It also dealt with sensitive topics, which I felt my personality was well suited to discuss with patients.”
Patient Ratings and Comments
Star ratings and comments are only available for medical oncologists and radiation oncologists. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.